| 000 | 01667 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516131934.0 | ||
| 264 | 0 | _c20130912 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1791-2431 | ||
| 024 | 7 |
_a10.3892/or.2013.2240 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Zengguang | |
| 245 | 0 | 0 |
_aDownregulation of Src enhances the cytotoxic effect of temozolomide through AKT in glioma. _h[electronic resource] |
| 260 |
_bOncology reports _cApr 2013 |
||
| 300 |
_a1395-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDacarbazine _xadministration & dosage |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 |
_aGlioma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aOncogene Protein v-akt _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTemozolomide |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 |
_asrc-Family Kinases _xgenetics |
| 700 | 1 | _aSun, Jikui | |
| 700 | 1 | _aLi, Xue | |
| 700 | 1 | _aYang, Shuyuan | |
| 700 | 1 | _aYue, Shuyuan | |
| 700 | 1 | _aZhang, Jianning | |
| 700 | 1 | _aYang, Xuejun | |
| 700 | 1 | _aZhu, Tao | |
| 700 | 1 | _aJiang, Rongcai | |
| 700 | 1 | _aYang, Weidong | |
| 773 | 0 |
_tOncology reports _gvol. 29 _gno. 4 _gp. 1395-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/or.2013.2240 _zAvailable from publisher's website |
| 999 |
_c22437182 _d22437182 |
||